A population approach to renal replacement therapy epidemiology: Lessons from the EVEREST study

Nephrology Dialysis Transplantation

Volumn 29, Issue 8, 2014, Pages 1494-1499

  Caskey, Fergus J ^a,b   Jager, Kitty J ^c  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Aetiology; Epidemiology; Macroeconomics; Renal replacement therapy; Renal service organization

Indexed keywords

CHRONIC KIDNEY DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; END STAGE RENAL DISEASE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH STATUS; HEMODIALYSIS; HUMAN; INCIDENCE; METHODOLOGY; PERITONEAL DIALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RELIABILITY; RENAL REPLACEMENT THERAPY; REVIEW; SOCIOECONOMICS; SURVIVAL TIME;

AETIOLOGY; EPIDEMIOLOGY; MACROECONOMICS; RENAL REPLACEMENT THERAPY; RENAL SERVICE ORGANIZATION;

HUMANS; KIDNEY FAILURE, CHRONIC; MORBIDITY; RENAL REPLACEMENT THERAPY; RESEARCH DESIGN; WORLD HEALTH;

EID: 84905018834     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft390     Document Type: Review

References (42)

1. Rose G. Sick individuals and sick populations. Int J Epidemiol 2001; 30: 427-432; discussion 433-434
2. Ayotte JD, Baris D, Cantor KP et al. Bladder cancer mortality and private well use in New England: An ecological study. J Epidemiol Community Health 2006; 60: 168-172
3. Last JM. A Dictionary of Epidemiology. New York, NY: Oxford University Press, 1995
4. U.S. Renal Data System. USRDS 2011 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases, 2011
5. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284
6. Sparke C, Moon L, Green F et al. Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation. Am J Kidney Dis 2013; 61: 413-419
7. Kerr M, Bray B, Medcalf J et al. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant 2012; 27 (Suppl 3): Iii73-iii80
8. Berlyne GM. Over 50 and uremic equals death. The failure of the British National Health Service to provide adequate dialysis facilities. Nephron 1982; 31: 189-190
9. Held PJ, Brunner F, Odaka M et al. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 1990; 15: 451-457
10. Young EW, Goodkin DA, Mapes DL et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int 2000; 57: S74-S81
11. Khan IH, Campbell MK, Cantarovich D et al. Survival on renal replacement therapy in Europe: Is there a 'centre effect'? Nephrol Dial Transplant 1996; 11: 300-307
12. Caskey FJ, Wordsworth S, Ben T et al. Early referral and planned initiation of dialysis: What impact on quality of life? Nephrol Dial Transplant 2003; 18: 1330-1338
13. Wordsworth S, Ludbrook A, Caskey F et al. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ 2005; 6: 38-44
14. Caskey FJ, Schober-Halstenberg HJ, Roderick PJ et al. Exploring the differences in epidemiology of treated ESRD between Germany and England andWales. Am J Kidney Dis 2006; 47: 445-454
15. Caskey FJ, Stel VS, Elliott RF et al. The EVEREST study: An international collaboration. NDT Plus 2010; 3: 28-36
16. Caskey FJ, Kramer A, Elliott RF et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant 2011; 26: 2604-2610
17. Kramer A, Stel VS, Caskey FJ et al. Exploring the association between macroeconomic indicators and dialysis mortality. Clin J Am Soc Nephrol 2012; 7: 1655-1663
18. Yang WC, Hwang SJ. Taiwan Society of Nephrology. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: The impact of national health insurance. Nephrol Dial Transplant 2008; 23: 3977-3982
19. McKenzie JK,Moss AH, Feest TG et al. Dialysis decision making in Canada, the United Kingdom, and the United States. Am J Kidney Dis 1998; 31: 12-18
20. Marcelli D, Stannard D, Conte F et al. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 1996; 50: 1013-1018
21. Goodkin DA, Young EW, Kurokawa K et al. Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects. Am J Kidney Dis 2004; 44(5 Suppl 2): 16-21
22. Foley RN, Hakim RM. Why is the mortality of dialysis patients in the United States much higher than the rest of the world? J Am Soc Nephrol 2009; 20: 1432-1435
23. Robinson BM, Port FK. International hemodialysis patient outcomes comparisons revisited: The role of practice patterns and other factors. Clin J Am Soc Nephrol 2009; 4(Suppl 1): S12-S17
24. van de Luijtgaarden MW, Jager KJ, Stel VS et al. Global differences in dialysis modality mix: The role of patient characteristics, macroeconomics and renal service indicators. Nephrol Dial Transplant 2013; 28: 1264-1275
25. Castledine C, Gilg J, Rogers C et al. UK Renal Registry 13th Annual Report (December 2010): Chapter 15: UK renal centre survey results 2010: RRT incidence and use of home dialysis modalities. Nephron Clin Pract 2011; 119(Suppl 2): 255-267
26. Murtagh FE, Addington-Hall JM, Higginson IJ. The value of cognitive interviewing techniques in palliative care research. Palliat Med 2007; 21: 87-93
27. World Health Organisation. The World Health Report 2000: Health Systems: Improving Performance. World Health Organisation, Geneva, 2000
28. Darby CV, Valentine N, Murray CJL et al. Strategy on measuring Responsiveness. World Health Organisation, Geneva, 2003
29. International Diabetes Federation. IDF Diabetes Atlas, 5th edn. Brussels: International Diabetes Federation, 2012
30. Yliharsila H, Lindstrom J, Eriksson JG et al. Prevalence of diabetes and impaired glucose regulation in 45-To 64-year-old individuals in three areas of Finland. Diabet Med 2005; 22: 88-91
31. Gulliford MC, Ashworth M, Robotham D et al. Achievement of metabolic targets for diabetes by English primary care practices under a new system of incentives. Diabet Med 2007; 24: 505-511
32. OECDiLibrary. OECD Regions at a Glance 2011, 2011. http:// www.oecd-ilibrary.org (21 April 2013, date last accessed)
33. Castledine CI, Gilg JA, Rogers C et al. How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population? Nephrol Dial Transplant 2012; 27: 3943-3950
34. Castledine CI, Gilg JA, Rogers C et al. Renal centre characteristics and physician practice patterns associated with home dialysis use. Nephrol Dial Transplant. 2013; 28: 2169-2180
35. Couchoud C, Guihenneuc C, Bayer F et al. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence. Nephrol Dial Transplant 2012; 27: 2312-2322
36. Kidney Health For Life (KH4L). Chronic Kidney Disease (CKD) Inventory. http://www.kidney.ca/document.doc?Id=3865&erid=0 (28 April 2013, date last accessed)
37. Harambat J, van Stralen KJ, Schaefer F et al. Disparities in pediatric kidney transplantation policies, practices and rates across Europe. Am J Transplant 2013; 13: 2066-2074
38. European Society of Paediatric Nephrology. ESPN/ERA-EDTA Registry Newsletter 2012. http://www.espn-reg.org/files/ Newsletter%20ESPN%20ERAEDTA%20registry%202012.pdf (28 April 2013, date last accessed)
39. Nanda A, Nossikov A, Prokhorskas R et al. Health in the central and eastern countries of the WHO European Region: An overview. World Health Stat Q 1993; 46: 158-165
40. Balabanova D, McKee M, Pomerleau J et al. Health service utilization in the former Soviet Union: Evidence from eight countries. Health Serv Res 2004; 39(6 Pt 2): 1927-1950
41. Karanikolos M, Mladovsky P, Cylus J et al. Financial crisis, austerity, and health in Europe. Lancet 2013; 381: 1323-1331
42. Houston M, Day M, de Lago M et al. Health services across Europe face cuts as debt crisis begins to bite. BMJ 2011; 343: D5266